CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-17 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −1,477 | 6,076 | ||
| 2020-07-15 | Shah Jatin EVP, Chief Medical Officer | Sale | −589 | $19.46 | $11K | 43,229 |
| 2020-07-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-07-15 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $19.43 | $146K | 756,489 |
| 2020-07-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 1,424 | ||
| 2020-07-15 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-07-15 | Shacham Sharon President & CSO | Sale | −7,500 | $19.43 | $146K | 756,489 |
| 2020-07-15 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 1,424 | ||
| 2020-07-11 | Shah Jatin EVP, Chief Medical Officer | Exercise or conversion | +2,413 | 43,172 | ||
| 2020-07-11 | Shah Jatin EVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −2,413 | 7,237 | ||
| 2020-07-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $4.75 | $36K | 562,622 |
| 2020-07-10 | Kauffman Michael Chief Executive Officer | Sale | −7,200 | $18.98 | $137K | 555,422 |
| 2020-07-10 | Kauffman Michael Chief Executive Officer | Sale | −300 | $19.71 | $6K | 555,122 |
| 2020-07-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 333,561 | ||
| 2020-07-10 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 562,622 |
| 2020-07-10 | Shacham Sharon President & CSO | Sale | −7,200 | $18.98 | $137K | 555,422 |
| 2020-07-10 | Shacham Sharon President & CSO | Sale | −300 | $19.71 | $6K | 555,122 |
| 2020-07-10 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 333,561 | ||
| 2020-07-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $4.75 | $36K | 763,989 |
| 2020-07-09 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $19.53 | $146K | 756,489 |
Page 22 of 29 · 570 trades